Acid-PEG3-C2-Boc
Code | Size | Price |
---|
TAR-T14101-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T14101-500mg | 500mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Images
Documents
Further Information
Bioactivity:
Acid-PEG3-C2-Boc is a compound used as a linker in the synthesis of PROTACs to facilitate the degradation of EGFR and the inhibition of mTOR[1][2]. It is classified as a PEG- and alkyl/ether-based PROTAC linker.
CAS:
1807539-06-5
Formula:
C14H26O7
Molecular Weight:
306.35
Purity:
0.98
SMILES:
O=C(O)CCOCCOCCOCCC(=O)OC(C)(C)C
References
Christopher Semko, et al. Rapamycin analogs as mtor inhibitors. WO 2018204416 A1.
Nathanael Gray, et al. Bifunctional molecules for degradation of egfr and methods of use. WO2017185036A1.